-Yoshinori Ito Researcher Activity Profile

Research Author Detailed Information 

Yoshinori Ito Publication Rate By Year

Yoshinori Ito has published 1 paper(s) in 2003, 14 paper(s) in 2007, 1 paper(s) in 2008, for a total of 16 research publications in total.

Yoshinori Y Ito Author Information

LAST NAME: ito

FIRST NAME: yoshinori

INITIALS: Y

AFFILIATION:

Papers

Yoshinori Ito's Publication Record

1. Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or older. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
2. Phase I study of cisplatin analogue nedaplatin, paclitaxel, and thoracic radiotherapy for unresectable stage III non-small cell lung cancer. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. isekine@ncc.go.jp
3. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Year Published: 2003
Department of Molecular Medicine, Sapporo Medical University, Japan.
4. Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer. Year Published: 2007
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.
5. Histological features of breast cancer, highly sensitive to chemotherapy. Year Published: 2007
Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research.
6. Assessment of hormone receptor status in breast cancer. Year Published: 2007
Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
7. Association between Decreased Kidney Function and Endotoxin Receptor CD14 C-159T Polymorphism among Japanese Health Check-up Examinees. Year Published: 2007
Department of Preventive Medicine / Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Nagoya, Japan.
8. Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer. Year Published: 2007
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.
9. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection. Year Published: 2007
Department of Virology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan.
10. Assessment of hormone receptor status in breast cancer. Year Published: 2007
Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. rie.horii@jfcr.or.jp
11. Histological features of breast cancer, highly sensitive to chemotherapy. Year Published: 2007
Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto-ku, Tokyo, 135-8550, Japan. rie.horii@jfcr.or.jp
12. Association between decreased kidney function and endotoxin receptor CD14 C-159T polymorphism among Japanese health check-up examinees. Year Published: 2007
Department of Preventive Medicine / Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan. rieokada@med.nagoya-u.ac.jp
13. Histological features of breast cancer, highly sensitive to chemotherapy. Year Published: 2007
Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto-ku, Tokyo, 135-8550, Japan. rie.horii@jfcr.or.jp
14. Assessment of hormone receptor status in breast cancer. Year Published: 2007
Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. rie.horii@jfcr.or.jp
15. Dose-finding phase I and pharmacokinetic study of capecitabine (Xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer. Year Published: 2008
Department of Surgery and Breast Oncology, Division of Clinical Trials and Research, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
16. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection. Year Published: 2007
Department of Virology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan.